City halts use of Johnson & Johnson Vaccine

City halts use of Johnson & Johnson Vaccine

The following is a statement from Chief Public Health Officer Denise Fair

Based on the recommendation from the CDC and FDA, the Detroit Health Department is halting the use of the Johnson & Johnson vaccine until further notice. The city has a sufficient supply of Moderna and Pfizer to vaccinate everyone who had an appointment scheduled this week at the Northwest Activity Center or the neighborhood clinics for a J&J shot.  If you were scheduled for a J&J shot and want to keep your same appointment, you will be given the Moderna or Pfizer vaccine.  You will receive an appointment for your second dose 3-4 weeks later.  Appointments at the TCF center and Saturday community centers are unaffected by this announcement.  They have always been Pfizer/Moderna.


For more information on vaccine appointments and vaccination sites in your area visit our COVID-19 Vaccination Site page. 

Dear Detroit Residents,

The CDC and FDA has provided guidance at this time to halt administration of the Johnson and Johnson COVID-19 vaccine following 6 cases of a rare type of blood clot (cerebral venous sinus thrombosis) identified in women between 18 to 48 years of age. These cases were identified less than 2 weeks after their doses and further analysis of each case will be reviewed on April 13th, 2021, to determine next steps for administration of the vaccine.

6.8 million doses have been administered, and although these cases are one in one million, we are recommending that individuals contact their healthcare provider in the event that one experiences severe headache, abdominal pain, leg pain, or shortness of breath within 3 weeks after receiving the Johnson and Johnson vaccine. Please ensure reporting of such events to the Vaccine Adverse Event Reporting System in order to continue this very important surveillance on additional cases that may emerge.

Our first priority is to ensure the safety and health of our community, and we will update you with the most accurate and up to date information as it is received.

Najibah K. Rehman, MD, MPH
Medical Director